Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Innate Pharma SA
< Previous
1
2
3
4
Next >
Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
June 10, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
June 08, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of June 1, 2023
June 07, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR’579 / IPH6101 in R/R AML
May 26, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
May 23, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Outcome of Innate Pharma’s 2023 Annual General Meeting
May 12, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
May 10, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of shares and voting rights of Innate Pharma as of May 1, 2023
May 09, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for Q1 Business Update
May 03, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting
May 03, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq
April 26, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conference
April 21, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023
April 18, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
April 07, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Files Its 2022 Universal Registration Document (Document d’enregistrement universel) and 2022 Annual Report on Form 20-F
April 06, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
April 03, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
March 23, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of March 1, 2023
March 20, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
March 16, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Provides Update on Silicon Valley Bank Exposure
March 13, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
February 21, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
February 07, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
January 25, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia in Nature Biotechnology
January 16, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
December 19, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
SNY
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022
December 10, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
December 09, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
December 01, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports Third Quarter Financial Results
November 14, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
November 07, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.